ArticleBlood advances2025
Linhares Y, Freytes CO, Cherry M, et al. OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL. Blood Adv. 2024;8(23):6114-6126.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.